A verified Thymosin Alpha-1 COA provides definitive analytical proof of chemical identity, sequence integrity, and precise purity for laboratory research. PX1 Research delivers standardized 5mg vials accompanied by lot-specific RP-HPLC chromatograms, mass spectrometry validation, and endotoxin assays to ensure maximum reproducibility across preclinical models.
A verified Thymosin Alpha-1 COA provides definitive analytical proof of chemical identity, sequence integrity, and precise purity for laboratory research. PX1 Research delivers standardized 5mg vials accompanied by lot-specific RP-HPLC chromatograms, mass spectrometry validation, and endotoxin assays to ensure maximum reproducibility across preclinical models.
A lot-specific **thymosin alpha-1 coa** serves as the primary standard of quality control for biochemical research. Thymosin Alpha-1 (Tα1) is an acidic 28-amino acid synthetic peptide (sequence: Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH) with a theoretical molecular mass of approximately 3108.5 Da. Because peptide degradation products, counterion residues, and incomplete synthetic sequences can compromise cell-based and in vitro experiments, obtaining an authentic Certificate of Analysis (COA) is essential prior to trial initialization.
When evaluating a **thymosin alpha-1 purity** report, principal investigators must verify three primary metrics: overall peptide purity expressed as a percentage of total chromatographic peak area, molecular identity matched via mass spectrometry peak assignment, and residual bioburden levels via bacterial endotoxin testing. Every batch of Thymosin Alpha-1 5mg supplied by PX1 Research undergoes rigorous testing at independent ISO 17025 accredited laboratories to validate these exact metrics.
Achieving consistent quantitative outcomes in structural biology and cell culture assays requires ultra-pure peptide reagents. The benchmark for research-grade **thymosin alpha-1 purity** is ≥98.0% by Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC). High-purity reagents prevent non-specific baseline activity, receptor cross-reactivity, and unexpected cellular toxicity caused by truncated sequence fragments.
To ensure analytical transparency, PX1 Research subjects every batch to comprehensive analytical protocols detailed in our peptide purity testing guide. This rigorous verification pipeline ensures that researchers receive uncompromised compounds, free from TFA (trifluoroacetic acid) overload or unidentified organic impurities that could otherwise skew experimental data.
To maintain complete reproducibility across longitudinal studies, PX1 Research implements strict analytical parameters across all production runs. Research facilities evaluating suppliers should compare key quality indicators before selecting reagents for institutional use:
• **RP-HPLC Quantification:** Area-under-curve (AUC) integration confirming ≥98.0% target peptide concentration. • **Mass Spectrometry Validation:** Electrospray Ionization (ESI-MS) confirming exact monoisotopic mass without deletion sequences. • **Endotoxin Quantification:** Chromogenic LAL assay verifying <0.01 EU/μg limits to protect sensitive cell cultures. • **Domestic Synthesis & Storage:** Fully manufactured in US GMP-compliant facilities with climate-controlled storage in California and Arizona. • **Traceable Documentation:** QR-coded, lot-specific COAs accessible directly from our PX1 research library.
Interpreting a **thymosin alpha-1 coa** requires a detailed technical understanding of analytical chromatograms. On an RP-HPLC trace, the primary compound peak should appear as a sharp, symmetrical retention time signal with minimal tailing or baseline drift. Any secondary peaks indicate short-chain synthesis failures, acetylated side-products, or oxidations (such as methionine or cysteine modifications, though Tα1 lacks these specific residues, sequence hydrolysis can occur at aspartic acid sites).
Electrospray Ionization Mass Spectrometry (ESI-MS) complements HPLC by confirming the exact molecular mass-to-charge ratio (m/z). Because Thymosin Alpha-1 carries an N-terminal acetyl group, the total molecular weight must reflect this 42 Da addition (3108.5 Da). A validated COA from PX1 Research documents both single-charged and multi-charged ions, establishing unambiguous proof of full-length 28-amino acid assembly.
In preclinical studies evaluating tissue response, cellular signaling, and immune system modulation, researchers frequently compare Thymosin Alpha-1 with other regulatory peptides. While Tα1 acts primarily via Toll-like receptor (TLR2/TLR4/TLR9) signaling cascades to modulate nuclear factor kappa B (NF-κB) pathways in T-lymphocytes and dendritic cell models, alternative peptides target complementary signaling mechanisms.
For instance, researchers studying cytoskeletal remodeling and cell migration often utilize Thymosin Beta-4 5mg, an actin-sequestering peptide with distinct structural characteristics. Similarly, investigations focused on microvascular repair and cytoprotection frequently incorporate BPC-157 5mg, while antimicrobial and innate barrier research may require cathelicidin-derived agents like LL-37 5mg. Accessing verifiable COAs across all these targets ensures that multi-peptide preclinical trials maintain identical purity standards.
In vitro data indicate that Thymosin Alpha-1 modulates early-stage immune signaling pathways without inducing direct cytotoxicity. Preclinical models demonstrate that Tα1 upregulates major histocompatibility complex (MHC) Class I expression, enhances interleukin-2 (IL-2) production, and promotes the differentiation of immature CD4+/CD8+ T-cell populations in thymic epithelial co-cultures.
Furthermore, animal studies suggest that Tα1 exhibits protective regulatory effects during hyper-inflammatory responses by balancing pro-inflammatory and anti-inflammatory cytokine secretion (including IL-10 and IFN-γ). Researchers requiring consistent receptor kinetics rely on verified **thymosin alpha-1 purity** to prevent confounding results caused by trace peptide contaminants.
Bacterial endotoxins (lipopolysaccharides, LPS) present a major confounding variable in cellular signaling research. Even microgram quantities of LPS can activate TLR4 receptors independently, mimicking or masking the physiological effects of Thymosin Alpha-1 in cell culture models.
To mitigate this risk, PX1 Research subjects all standard lots to rigorous limulus amebocyte lysate (LAL) testing. Learn more about our bioburden standards on our endotoxin testing reference page. By enforcing strict endotoxin limits (<0.01 EU/μg), we ensure that observed cell culture responses stem solely from the synthetic peptide rather than bacterial impurities.
Thymosin Alpha-1 is supplied as a lyophilized (freeze-dried) powder under vacuum seal to ensure long-term shelf stability. For laboratory preparation, researchers should reconstitute the 5mg vial using sterile, preservative-free diluents such as sterile water for injection or sterile phosphate-buffered saline (PBS, pH 7.4). For assays requiring multi-dose sampling over extended timeframes, bacteriostatic water reconstitution can be utilized to prevent bacterial colonization.
Reconstitution should involve gentle swirling rather than aggressive vortexing to avoid mechanical shear stress and peptide aggregation. Once reconstituted, stock solutions should be aliquoted into single-use polypropylene microtubes and stored at -20°C or -80°C to prevent freeze-thaw degradation cycles.
PX1 Research caters directly to academic institutions, biotechnology companies, and contract research organizations (CROs) requiring dependable batch consistency. All orders ship same-day (Monday through Friday) from our climate-controlled distribution centers in California and Arizona, ensuring minimal transit times and optimal peptide stability.
For large-scale screening projects or continuous trial protocols, laboratories can secure bulk pricing and batch reservation through our wholesale lab account portal. Researchers can also browse our complete catalog of analytical-grade compounds across the all peptides directory.
How do I obtain a valid thymosin alpha-1 coa for my order?
Every lot of Thymosin Alpha-1 from PX1 Research includes a downloadable, verifiable Certificate of Analysis (COA). You can access the specific COA for your batch by scanning the QR code on the vial product packaging or by visiting our research documentation library with your lot number.
What is the certified thymosin alpha-1 purity level offered by PX1 Research?
PX1 Research guarantees a minimum thymosin alpha-1 purity of ≥98.0% as measured by Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC). Lot-specific purity percentages are clearly printed on each Certificate of Analysis.
How is mass spectrometry used to verify Thymosin Alpha-1?
Electrospray Ionization Mass Spectrometry (ESI-MS) measures the precise molecular mass of the peptide. For Thymosin Alpha-1, the observed mass must match the theoretical molecular weight of 3108.5 Da, confirming correct sequence synthesis and acetyl group capping.
What are the endotoxin limits on a PX1 Thymosin Alpha-1 COA?
PX1 Research enforces strict endotoxin limits of <0.01 EU/μg using chromogenic LAL testing protocols. This low bioburden level ensures that cell culture assays remain free from non-specific inflammatory activation caused by bacterial LPS.
What is the structural difference between Thymosin Alpha-1 and Thymosin Beta-4?
Thymosin Alpha-1 is a 28-amino acid peptide involved primarily in T-lymphocyte maturation and TLR signaling pathways. Thymosin Beta-4 is a 43-amino acid peptide that acts as an actin-monomer sequestering protein involved in cell motility and tissue remodeling models.
Which diluents are recommended for reconstituting Thymosin Alpha-1 in laboratory settings?
For cell culture and in vitro experiments, sterile phosphate-buffered saline (PBS, pH 7.4) or sterile nuclease-free water is recommended. If multi-use sampling is planned, bacteriostatic water containing 0.9% benzyl alcohol may be utilized.
How should lyophilized Thymosin Alpha-1 5mg vials be stored?
Lyophilized Thymosin Alpha-1 vials should be stored in a freezer at -20°C for long-term storage (up to 24 months). Once reconstituted, liquid aliquots should be kept at -20°C or -80°C and protected from repeated freeze-thaw cycles.
Are PX1 Research peptides synthesized in GMP-compliant facilities?
Yes. All PX1 Research peptides are manufactured in US-based GMP-compliant facilities adhering to ISO 9001 and ISO 17025 quality management systems, ensuring strict quality control from raw amino acid synthesis to final lyophilization.
What is the shipping timeframe for Thymosin Alpha-1 research orders?
Orders placed Monday through Friday before cut-off times ship same-day from our dual distribution facilities in California and Arizona, minimizing transit duration and temperature fluctuations.
How can academic and institutional laboratories order Thymosin Alpha-1 in bulk?
Institutional buyers and principal investigators can submit purchasing inquiries through the PX1 Research wholesale portal to receive volume pricing, batch reservations, and custom synthesis support.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.